EYPT - EyePoint Pharmaceuticals Inc. (EYPT) CEO Nancy Lurker on Q1 2021 Results - Earnings Call Transcript
EyePoint Pharmaceuticals, Inc. (EYPT) Q1 2021 Earnings Conference Call May 05, 2021, 08:30 ET Company Participants George Elston - CFO & Head, Corporate Development Nancy Lurker - President, CEO & Director Jay Duker - Chief Strategic Scientific Officer Scott Jones - Chief Commercial Officer Conference Call Participants Georgi Yordanov - Cowen and Company Jennifer Kim - Cantor Fitzgerald & Co. Devin Geiman - Guggenheim Securities Yi Chen - H.C. Wainwright & Co. Andrew D'Silva - B. Riley Securities I-Eh Jen - Laidlaw & Company Presentation Operator Welcome to the EyePoint First Quarter 2021 Financial Results Conference Call. [Operator Instructions]. I would now like to hand the conference over to your speaker today, George Elston, Chief Financial Officer. Please go ahead. George Elston Thank you, and thank you all for joining us on today's conference call to discuss EyePoint Pharmaceuticals' First Quarter 2021 financial results and recent corporate developments. With me
For further details see:
EyePoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q1 2021 Results - Earnings Call Transcript